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Abstract: Aim: This study examines the number and nature of investigations performed for
suspected PE in a large teaching hospital and the change in incidence and severity of
PE over a decade.  With availability of CT pulmonary angiography (CTPA), the number
of imaging investigations for suspected acute pulmonary embolism (PE) has been
increasing steadily. It has been hypothesised that this leads to increased detection of
small emboli and effective over-diagnosis.
Materials and methods: In this retrospective study, all patients investigated for
suspected PE using CTPA or lung scintigraphy during 10 years to March 2012 were
identified and their records reviewed. In the final year, all reportedly positive CTPA
cases were reviewed and PE severity calculated, for comparison with similar historical
data.
Results: From 2002 to 2012, total annual investigations for suspected acute PE
increased by 163% (805 to 2 121). CTPA increased by 325% (475 to 2 019). Detection
of PE increased by 121% (193 to 426 per annum), with stable distribution of severity
scores. The positive scan rate decreased from 24% to 20%. The mean age of patients
being investigated for PE increased from 56 to 63 years.
Conclusions: Increased detection of PE is not due to disproportionate increase in small
PEs, but to increased detection of PE of all severities. This finding supports the
hypothesis that PE is more common in the general population than previously
appreciated, which may represent an iceberg phenomenon of previously undetected
disease.
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Author Contributions
Reviewer #1: A well written interesting study. 
 
a. I think it would be useful to give the figures for 
decreased use of Q scans over the ten years and the 
percentage now investigated by Q vs CTPA. 
Numbers now included in text, line 107.  
 
b. Was there any difference in diagnosis rate between Q and 
CT? 
Insert at line 115: In the final year 9% of 102 Q 
scans and 20% of 2 019 CTPAs were positive. 
 
c. You state the your catchment population increased by only 
7% during the study but what happend to patient 
attendences during the period. They may have increased by 
more than 7% 
There are many different types of hospital 
attendance and it is difficult to give a useful 
answer here.  We understand that A&E attendances, 
for instance, are increasing month on month. We 
feel that the most important observation is the 
relationship of incidence to the population. All 
acute admissions for the catchment population were 
admitted to the hospitals studied and consequently 
we consider that the catchment population is the 
most appropriate denominator.    
No change made. 
 
d. In terms of factors that might have driven increased 
referral for investigation was there any change in care 
pathway e.g was d-dimer used througout period and did 
institution roll out any care pathway changes which may 
have contributed to increased investigation? 
Alteration beginning line 206: 
In a hospital setting, there is easier access to PE 
diagnostic imaging, and the way in which patients 
with suspected primary PE are looked after and 
investigated is changing which could partially 
explain the increase in radiological referrals. For 
instance there are new ‘ambulatory care’ pathways 
whereby patients can be anticoagulated and return 
the following day for CTPA. 
 
  
Anonymous list of revisions
Reviewer #2: 
a. The paper has looked at a decade of investigations for 
acute PE (both CTPA and VQ) and compared the numbers of 
scans performed, the number of positive scans 
and  the'severity' of the PE with historical data 
primarily to test the hypothesis that the number of 
increase in positive scans is due to the increased 
detection of smaller PEs. 
 
b. They concluded that there has been an increased incidence 
of PE but this cannot be attributed to increased 
detection of smaller PEs with the overall 'severity' 
score remaining similar to historical data. 
 
c. The paper discusses well why there may be an increase in 
the number of PE diagnosis (ultimatetly presumbably 
becasue we are doing more investigations) and argues that 
there the management of 'smaller PEs' remains unclear and 
perhaps anticoagulation for this group could be withheld 
- this would be a more powerful argument if there was any 
outcome data between the periods studied (?)- although it 
is mentioned in the introduction that a systematic review 
showed no includable studies in this regard, this may be 
worth reiterating in the discussion - was outcome worse 
when we weren't diagnosing all these PEs? 
It is difficult to answer this, as we have started 
with people being scanned.  We are not aware of 
accurate death rates due to TED for our population. 
This is specifically discussed by Wiener et al. for 
USA population data. 
We highlight this topic cautiously in our introduction 
to illustrate some of the controversy and ongoing 
investigation in the field. No change made. 
 
d. I challenge some of the text regarding 'CTPA being better 
than V/Q at diagnosing subsegemental PE' (eg Intro 22-25 
and discussion 158-162) - I believe the literature on 
this is not entirely as clear cut especially in the 
current climate with SPECT VQ which has shown good 
results and is perhaps better than CTPA at smaller PE. 
While not especially relevant to the study itself I think 
SPECT VQ should be discussed and referenced more to 
reflect emerging modern clinical practice. 
We agree that SPECT VQ is an important development and 
we are grateful for your prompt to include this in the 
discussion. 
Change to line 224: CTPA is currently the first line… 
Change to line 257: SPECT V/Q scanning techniques are 
becoming established elsewhere and we believe that 
this will play an increasing part in investigation of 
suspected PE. (28, 29) 
 
Lines 22-25 refer specifically to historic published 
work, central to the arguments in the Weiner paper. No 
change made. 
 
e. The Modified Miller Score needs explanation. I maybe 
wrong but I think this reflects scoring of segmental PE. 
What happens to the scoring in isolated sub-segmental 
PEs? 
You’re correct - the modified Miller score is not 
explicit regarding this.  Referring back to the Miller 
Score, involvement of a vessel (or segment) was 
sufficient to incurr 1 point. 
Added, line 55:  With specific regard to subsegmental 
emboli, each bronchopulmonary segment containing an 
embolus (or emboli) would contribute one point to the 
score, analogous to ‘involvement’ in the Miller Score(19), 
unless superceded by a more proximal embolus. 
Abstract 
Aim: This study examines the number and nature of investigations 
performed for suspected PE in a large teaching hospital and the change in 
incidence and severity of PE over a decade.  With availability of CT 
pulmonary angiography (CTPA), the number of imaging investigations 
for suspected acute pulmonary embolism (PE) has been increasing 
steadily. It has been hypothesised that this leads to increased detection of 
small emboli and effective over-diagnosis. 
Materials and methods: In this retrospective study, all patients 
investigated for suspected PE using CTPA or lung scintigraphy during 10 
years to March 2012 were identified and their records reviewed. In the 
final year, all reportedly positive CTPA cases were reviewed and PE 
severity calculated, for comparison with similar historical data. 
Results: From 2002 to 2012, total annual investigations for suspected 
acute PE increased by 163% (805 to 2 121). CTPA increased by 325% 
(475 to 2 019). Detection of PE increased by 121% (193 to 426 per 
annum), with stable distribution of severity scores. The positive scan rate 
decreased from 24% to 20%. The mean age of patients being investigated 
for PE increased from 56 to 63 years. 
Conclusions: Increased detection of PE is not due to disproportionate 
increase in small PEs, but to increased detection of PE of all severities. 
This finding supports the hypothesis that PE is more common in the 
general population than previously appreciated, which may represent an 
iceberg phenomenon of previously undetected disease. 
Abstract
10 years of Imaging for Pulmonary Embolism - 1 
Too Many Scans, or the Tip of an Iceberg? 2 
Introduction 3 
Objective: To assess the impact of a putative increase in detection of 4 
small PEs, we have measured the rate and outcomes of investigation for 5 
suspected acute PE in our institution over the decade 2002-2012. 6 
Venous thrombo-embolism (VTE), including Deep Vein Thrombosis 7 
(DVT) and Pulmonary Embolism (PE) is a frequent and important 8 
diagnosis.(1, 2) Despite routine prophylaxis, it also remains a leading 9 
cause of secondary mortality and morbidity in many common healthcare 10 
scenarios, for example maternity,(3) and lower limb arthroplasties.(4) 11 
As VTE is prevalent, dangerous and treatable, it is not surprising to 12 
encounter controversy regarding its diagnosis and management.(5, 6) A 13 
recent article argues that modern CTPA makes increasingly sensitive 14 
detection of ‘small emboli’, and so alters the spectrum of diagnosis.(7) 15 
Figure 1 shows some example CTPA images. The authors hypothesised 16 
that additional inclusion of small emboli (previously undetectable) 17 
effectively causes overdiagnosis and overtreatment. They highlighted an 18 
experimental study reported in 2007,(8) in which patients with suspected 19 
PE were randomised to either V/Q scanning or CTPA. Appropriate 20 
patient selection, sufficient numbers and modern techniques made this a 21 
robust comparison. More PE were detected in the CTPA arm, but no 22 
significant differences in outcome were observed. In the CTPA group, 23 
7% of those with PE had isolated, subsegmental emboli, less likely to be 24 
detected with a V/Q scan. 25 
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In combination, the findings above support the hypothesis: ‘It is not 26 
beneficial to anticoagulate patients with small PEs’. This was the topic of 27 
a systematic review,(9, 10) which found no includable studies and a 28 
multicentre trial in North America is currently recruiting to test it.(11) 29 
However it is worth considering that treatment of PE is partly secondary 30 
prevention. A PE causing presentation might be the forerunner of a 31 
preventable secondary event. In addition to dissolution of the embolus 32 
causing the presentation, the treatment also targets the thrombotic source 33 
of emboli. 34 
Pulmonary embolism is a difficult clinical diagnosis with varied and 35 
sometimes minimal symptoms and signs. As a result, patients being 36 
investigated for suspected PE may have various other serious illnesses. 37 
Patients with clinically suspected PE in whom the diagnosis is refuted 38 
show a higher mortality than those in whom the diagnosis is confirmed 39 
(17% vs 11% at 6 months).(12) In a more recent study, patients with 40 
negative CTPA had a 14% 3-month mortality.(13) It is also relevant to 41 
consider that sub-clinical PE is a common incidental finding on CT scans 42 
performed for other reasons,(14) and also at post mortem.(15) In 43 
summary, patients being referred with suspected acute PE are a 44 
heterogeneous population with many other potential diagnoses and there 45 
is a recognised prevalence of sub-clinical VTE. 46 
Methods 47 
This work builds on previous published data from this institution.(16, 17) 48 
An earlier paper reports a cohort of consecutive positive CTPAs (n=504) 49 
from 2001 to 2004, with standardised severity scoring. We have 50 
performed a retrospective analysis of all CTPA and Q-scan referrals in 51 
the year ending 31/03/12, with comparable severity scoring using the 52 
modified Miller score.(18) For some analyses, the Miller scores have 53 
been categorised as Mild (1-5), Moderate (6-10), and Severe (11-16). 54 
With specific regard to subsegmental emboli, each bronchopulmonary 55 
segment containing an embolus (or emboli) would contribute one point to 56 
the score, analogous to ‘involvement’ in the Miller Score(19), unless 57 
superceded by a more proximal embolus. The project was approved by 58 
the local research ethics authority. 59 
Retrospective Case Reviews 60 
All CTPA and Q scan records in the year ending 31/03/12 were retrieved 61 
from the hospital information system, numbering 2 138. Referrals and 62 
reports were evaluated by two independent physicians. 17 cases were 63 
excluded because the indication was not suspected acute PE, for instance 64 
the investigation of pulmonary hypertension. CTPA reports detailing new 65 
PEs were identified. These cases were reviewed and PE severity 66 
quantified with a Modified Miller score, under supervision of a chest 67 
radiologist with 20 years of experience. 68 
Similar hospital record searches were used to identify the rates of 69 
referral for Q-scans and CTPAs in the years between 2001 and 2012. 70 
In seeking to quantify the incidence of PE, this study is limited to 71 
cases where suspected acute PE has been referred to Clinical Radiology 72 
for imaging with Q-scan or CTPA. There may be other clinical routes for 73 
diagnosis of PE that are not included in this analysis.  74 
Imaging Protocols 75 
Although our imaging practices have developed over the period of study, 76 
the extraction of standardised categorical data means that valid 77 
comparisons can be made. Current protocols are described: 78 
CT Pulmonary Angiography 79 
CTPA is performed using a 75ml injection of Intravenous contrast 80 
medium (Iomeron 400), given by pump injection at 4.5 ml/s (Dose 81 
reduced to 50mls when age >40 and mass <95kg). 64-slice helical CT 82 
acquisition from hyoid to costophrenic angles following an inspiratory 83 
breath-hold instruction, with arms abducted. The scan is triggered on 84 
detection of the leading contrast in the right atrium. 85 
Pulmonary Scintigraphy 86 
Planar images of the thorax are obtained in 8 projections, beginning 87 
immediately after intravenous injection of 80 MBq of Tc99 labelled 88 
macro-aggregated albumin. Total scan time is approximately 15 minutes 89 
using a 2-head gamma camera, and low-energy high-resolution parallel 90 
collimators. 91 
Analyses 92 
Statistical and graphical analyses were performed by NM using Microsoft 93 
Excel and GraphPad Prism. Each patient’s age in complete years was 94 
calculated using the date of birth and date of scan. Age distributions were 95 
assessed with 10-year histogram bins, centred on each multiple of 10 (i.e. 96 
5-14, 15-24 etc.). In addition to graphical analysis, distribution of PE 97 
severity scores was assessed for change using Chi-squared analysis of 98 
normalised data, the table having 16 rows and 2 columns, therefore 15 99 
degrees of freedom. 100 
Results 101 
Increased rate of investigation and shift to CTPA 102 
From 2002 to 2012 there was a 163% increase in the annual rate of 103 
investigation for suspected acute PE (from 805 to 2 121). In this same 104 
period the number of CTPAs performed per year has increased by 325% 105 
(from 475 to 2 019). This is a change from 45% of total investigations to 106 
96% as%. Over the same period, Q-scans have fallen from 566 to 102 per 107 
year, from 55% to 4% of investigations. These changes are illustrated in 108 
Figure 2. Further analysis of the referrals in the first and last of these 109 
years in Figure 3 reveals that Q-scanning is now most commonly 110 
performed in younger patients, peaking at approximately 30 years of age. 111 
Increased Detection of PE 112 
Detection of PE increased by 121% (from 193 to 426 per annum). The 113 
number of investigations has increased even more, resulting in a slight 114 
decrease in PE-positive scan rate from 24% to 20%. In the final year 9% 115 
of 102 Q scans and 20% of 2 019 CTPAs were positive. The population 116 
served by our hospital has increased by 7% over this period,(20) so a 117 
greater rate of diagnosis in our practice represents increased incidence of 118 
acute PE diagnosed radiologically. 119 
Distribution of PE Severity Scores 120 
PE severity scores show a stable distribution over the recent decade 121 
(Figure 4), with the proportion of severe PEs (modified Miller score 11 or 122 
greater) stable at 36% (p=0.85). There is no significant difference 123 
between samples on Chi-squared analysis of the categorical data. (Chi-124 
square=9.58, p=0.85). Although variation is not significantly different 125 
when considering the distribution of all scores, the proportion of cases 126 
with a modified Miller score of 1 has increased from 11% to 16%. 127 
The comparison above uses the cohort previously described by Wong 128 
et al.,(17) with data from more than one year in the older set. Subset 129 
analysis of the year ending March 31st 2002, is not shown, but a similar 130 
pattern is present (Chi-square=17.5, p=0.29). That sample is smaller, 131 
n=134, in part because during that year many patients had PE diagnosed 132 
by scintigraphy and so modified Miller scoring of severity is not 133 
applicable. 134 
Age of Population Being Investigated 135 
The mean age of patients being investigated for PE (both Q-scan and 136 
CTPA) has increased from 56 years in 2001/02 to 63 years in 2011/12 137 
(95% CI +6.1 to +8.9 years). The proportion of patients being 138 
investigated who are over 80 years of age has increased from 12% to 139 
21%. Increasing age is represented in the Figure 3 histograms, where the 140 
mode changes from 65 to 80.  141 
The population of patients being investigated with CTPA is also older, as 142 
seen in Figure 5. The mode has changed from 70 to 80, and the mean 143 
from 61 to 65 (95% CI +1.6 to +5.2). 144 
 145 
Incidence of PE in all age groups 146 
To further investigate the increased incidence of PE, and the relationship 147 
to the changing age of the population, relative frequency plots are given 148 
for comparison in Figure 6. The positive results in each severity bracket 149 
are distributed across the age range, and reflect the age distribution of all 150 
CTPAs. There does not appear to be any anomalous increase in positive 151 
cases or severe cases associated with the increase in older patients. 152 
Discussion 153 
The incidence of PE diagnosed radiologically has more-than-doubled in a 154 
decade. This is a surprising finding, and might reasonably lead to the 155 
hypothesis that the ‘Increased number of emboli is due to detection of 156 
smaller emboli’, as advanced by Wiener, Schwartz and Woloshin.(7) 157 
However that hypothesis is refuted by our analysis of PE severity. The 158 
proportion of patients diagnosed with massive PE, within the group of 159 
patients with CTPA confirmed emboli, remains the same. This refutes the 160 
hypothesis that modern CTPA has caused a particular increase in 161 
diagnosis of small PE. The incidence of small PE has increased, but in 162 
proportion to the overall incidence.  163 
We do not contest that replacing isotope scintigraphy with CTPA in 164 
imaging for suspected PE has resulted in a greater number of smaller 165 
emboli being diagnosed, as demonstrated by Anderson et al. 2007.(8) Our 166 
data primarily relates to a continuing rise in the diagnosis of PE within 167 
patients investigated with CTPA. 168 
The size of PE that a scanner is able to identify is limited by the 169 
spatial resolution of CT, and this has remained fairly static at around 170 
1mm over the decade under investigation. Greater number of detectors 171 
and decreased acquisition times do improve co-ordination with the 172 
contrast bolus and breath hold to reduce artefacts from contrast dilution 173 
and respiratory motion respectively, but when the technique was 174 
satisfactory these were not restricting factors.  The small increase in the 175 
proportion of PE with a severity score of 1 (from 11% to 16%, see Figure 176 
4) may represent an effect of increased sensitivity to detection of smaller 177 
emboli but it does not account for the increased rate of detecting PE. 178 
A number of factors may underlie the increase in incidence during the 179 
study period. Although the population being investigated contains a 180 
greater proportion of older people, the age distribution of PE has changed 181 
in a similar fashion, without any major discrepancy in the age distribution 182 
of PE. Younger patients still have a similar proportion of positive studies, 183 
with no gross change in severity categorisation (Figure 6). The increased 184 
number of studies being performed means that the rate of diagnosis in 185 
each category has increased proportionally. 186 
We know from other reports that incidental PE are identified on CT 187 
scans investigating other diseases in both inpatients,(14) outpatients,(21) 188 
and on post mortem examinations.(15) Thus sub-clinical PE is a real 189 
entity and there may be an iceberg phenomenon, where we see only the 190 
tip and a significant proportion of disease remains undiagnosed. Increased 191 
suspicion of relevant symptoms by patients and clinicians could lead to 192 
an increased referral rate for imaging and thereby increased diagnosis, 193 
transferring subclinical PE to clinical PE. Because we are observing this 194 
increase in investigations that have been targeted to symptomatic PE, this 195 
would require a historical context when symptoms were previously not 196 
investigated, or were given an alternative (incorrect) diagnosis. 197 
It is possible that public awareness has increased causing more 198 
patients to present to medical care with their symptoms. We are 199 
anecdotally aware of recent media exposure of VTE and the emotive, 200 
politically polarised name ‘economy class syndrome’ has helped to raise 201 
its profile, although it is not necessarily accurate.(22) Another change 202 
may be that patients more often present directly to an emergency 203 
department rather than to primary care. In a hospital setting, there is 204 
easier access to PE diagnostic imaging, and the way in which patients 205 
with suspected primary PE are looked after and investigated is changing 206 
which could partially explain the increase in radiological referrals. For 207 
instance there are new ‘ambulatory care’ pathways whereby patients can 208 
be anticoagulated and return the following day for CTPA. 209 
We are also aware of recent activity to develop new injected and oral 210 
anticoagulants(23, 24) which contributes to a high awareness of thrombo-211 
embolic disease among medical professionals. Prescription of prophylaxis 212 
means that thrombo-embolic disease is routinely considered when 213 
admitting inpatients. 214 
The increasing rate of pulmonary emboli may reflect a decrease in 215 
the health of our population. Prevalence of chronic illness is 216 
increasing,(25) and the ensuing ‘multimorbidity’ is now seen as a 217 
significant challenge to healthcare providers.(26, 27) Successful 218 
management of previously fatal diseases (including thrombo-embolic 219 
disease) may be increasing the prevalence of chronic illness, and 220 
increasing the risk of secondary VTE. This may be a paradoxical effect of 221 
improved healthcare. 222 
CTPA has becomeis currently the first line test of choice for the 223 
investigation of suspected acute PE. For patients with suspected PE, a 224 
normal chest radiograph, and no history of asthma or chronic obstructive 225 
pulmonary disease, pulmonary perfusion scintigraphy remains the 226 
preferred investigation in our institution. When the radiograph is 227 
abnormal, or there is a history of chronic lung-disease, patients are 228 
referred for CTPA. It is suggested that increasing patient age and co-229 
morbidity mean that a larger proportion of patients are excluded from Q-230 
scans on the basis of chronic respiratory illness or chest radiograph 231 
abnormalities.  232 
Investigating suspected PE in pregnancy and the puerperium is a 233 
special clinical scenario. Q-scan is the preferred method due to a lesser 234 
dose of ionising radiation to maternal breasts.(28) This may, at least in 235 
part, explain why the Q-scan age distribution in Figure 3 has a mode of 236 
30 years. 237 
In most cases of suspected PE presenting outside daytime hours, 238 
patients are treated with subcutaneous low-molecular weight heparin, and 239 
imaging is deferred until the following morning. In cases where 240 
anticoagulation is contraindicated (e.g. some recent operations or a recent 241 
bleeding illness), or when important diagnostic doubt exists, imaging may 242 
be required immediately, which favours CTPA. 243 
The widespread use of CT in many other clinical scenarios means that 244 
CT services are well established and available. Intravenous contrast 245 
medium can be used ‘off the shelf’ and has a long shelf life, whereas 246 
Tc99m labelled Macro-agregated albumin requires on-site expertise for the 247 
harvesting and combination of radioisotope, whose mode of action 248 
requires instability. With few other indications for emergency 249 
radionuclide imaging, this is not available over the weekend in our 250 
institution. Meantime CTPA, being available, has become well accepted 251 
in emergencies, and imaging suspected PE over the weekend is 252 
commonplace.  It may follow that Q-scanning has become less familiar as 253 
a result of the success of CTPA, to the extent that it is not considered by 254 
referring clinicians, or even by some radiologists when prioritising CT 255 
referrals. SPECT V/Q scanning techniques are becoming established 256 
elsewhere and we believe that this will play an increasing part in 257 
investigation of suspected PE. (29, 30) 258 
Conclusions 259 
In our practice, the rate of investigations for acute PE has increased by a 260 
factor of 2.6 in the recent decade, with a large increase in CTPA and a 261 
reduction in Q-scans. 262 
The incidence of PE has increased by a factor of 2.2. The cause of the 263 
increased incidence of PE is not clear. Contrary to expectation, the later 264 
cohort of diagnosed PE shows a similar distribution of severity to the 265 
historic comparison. Frequent diagnosis of smaller emboli does not 266 
explain the increase in total numbers of PE being diagnosed. 267 
The most likely explanation for our findings is that prevalence of PE 268 
is greater than we were previously aware of (either clinically or 269 
radiologically). We hypothesise an iceberg phenomenon of undiagnosed 270 
disease. In this context, increased investigation will lead to increased 271 
detection. This would imply that our understanding of PE could still be 272 
improved. Another hypothesis is that our population is becoming less 273 
healthy, perhaps as a paradoxical consequence of greater investment in 274 
healthcare. 275 
PE is a spectrum of disease and the least severe PE (embolus in a 276 
single segmental artery or smaller) do represent a significant proportion 277 
of cases (16%). The optimal management of these patients remains 278 
unclear and it may be that these patients could be better treated without 279 
anticoagulants. 280 
281 
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Figure Legends 375 
FIGURE 1. Axial Images from Positive CT Pulmonary Angiograms 376 
Patients are scanned shortly after injection of intravenous contrast, timed for 377 
greatest opacification in pulmonary arteries. A: Multiple small emboli are 378 
present. Three centri-luminal filling defects are shown in cross-section in lower-379 
lobe segmental arteries. B:  Another patient with a ‘saddle embolus’ astride the 380 
pulmonary trunk bifurcation and filling defects in the proximal pulmonary 381 
arteries. Secondary cor pulmonale causes retrograde opacification in the 382 
azygous vein and delayed opacification of the aorta. 383 
FIGURE 2. Frequency of Investigations for Acute PE (stacked columns) 384 
FIGURE 3. Referrals for CTPA and Q Scan by Patient Age (stacked bars) 385 
FIGURE 4. Distributions of PE Severity Score 386 
Normalised frequency distributions of PE severity score on positive CTPAs in a 387 
previous cohort (n=504) and in 2011/12 (n=400). 388 
FIGURE 5. Histograms of CTPA Results by Patient Age 389 
FIGURE 6. Normalised Frequency distributions of CTPA Referrals and Results 390 
Age distribution of all CTPAs is shown as a line. Age distribution of positive 391 
cases is shown as bars which are subdivided by severity. 392 
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Highlights 
We have examined PE incidence, severity and rate-of-investigations over 
a decade. 
The rate of investigation has more-than doubled and PE incidence is 
increasing. 
This occurs in all age groups and without change in distribution of 
severity scores. 
This suggests an iceberg phenomenon due to subclinical disease. 
Highlights
